CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
140 hedge funds and large institutions have $1.16B invested in Clovis Oncology, Inc. in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 58 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
33% less call options, than puts
Call options by funds: $22.1M | Put options by funds: $33M
38% less capital invested
Capital invested by funds: $1.87B → $1.16B (-$711M)
Holders
140
Holding in Top 10
4
Calls
$22.1M
Puts
$33M
Top Buyers
| 1 | +$30.2M | |
| 2 | +$19M | |
| 3 | +$16.6M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$14.7M |
| 5 |
O
OppenheimerFunds
New York
|
+$14.4M |
Top Sellers
| 1 | -$32.9M | |
| 2 | -$26.2M | |
| 3 | -$15.3M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$13.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.3M |